An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy.

An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy.
复制标题

DOI:
10.1039/d0lc01216e
复制
发表时间:
2021-04-07
期刊:
影响因子:
6.1
通讯作者:
Hughes CCW
Hughes CCW
中科院分区:
工程技术1区
文献类型:
--
作者:
Hachey SJ;Movsesyan S;Nguyen QH;Burton-Sojo G;Tankazyan A;Wu J;Hoang T;Zhao D;Wang S;Hatch MM;Celaya E;Gomez S;Chen GT;Davis RT;Nee K;Pervolarakis N;Lawson DA;Kessenbrock K;Lee AP;Lowengrub J;Waterman ML;Hughes CCW

文献摘要

参考文献

被引文献

相似文献

大约95%的抗癌药物在临床前研究中表现出希望,但未能获得FDA批准用于临床。这种临床前管道的失败突出了对改进的生理相关体外模型的需求,这些模型可以更好地作为可靠的药物筛选和疾病建模工具。血管化微肿瘤(VMT)是一种新型的三维模型系统(芯片上肿瘤),它在透明的微流体装置内重现了复杂的人类肿瘤微环境,包括灌注的脉管系统,允许实时研究药物反应和肿瘤-基质相互作用。在这里,我们已经验证了这种微生理系统(MPS)平台用于研究结直肠癌(CRC),癌症相关死亡的第二大原因,通过显示VMT中的基因表达,肿瘤异质性和治疗反应比目前的标准药物筛选模式(包括二维单层培养和三维球体)更接近CRC肿瘤临床病理学模型。VMT重现了体内药物反应,也重建了肿瘤的细胞多样性。
Around 95% of anti-cancer drugs that show promise during preclinical study fail to gain FDA-approval for clinical use. This failure of the preclinical pipeline highlights the need for improved, physiologically-relevant in vitro models that can better serve as reliable drug-screening and disease modeling tools. The vascularized micro-tumor (VMT) is a novel three-dimensional model system (tumor-on-a-chip) that recapitulates the complex human tumor microenvironment, including perfused vasculature, within a transparent microfluidic device, allowing real-time study of drug responses and tumor–stromal interactions. Here we have validated this microphysiological system (MPS) platform for the study of colorectal cancer (CRC), the second leading cause of cancer-related deaths, by showing that gene expression, tumor heterogeneity, and treatment responses in the VMT more closely model CRC tumor clinicopathology than current standard drug screening modalities, including 2-dimensional monolayer culture and 3-dimensional spheroids. VMTs recapitulate in vivo drug responses and also reconstitute the cellular diversity of tumors.
DOI: 10.1016/j.drup.2012.01.006
发表时间: 2012-02
影响因子: 24.3
作者:
Correia, Ana Luisa;Bissell, Mina J.
通讯作者: Bissell, Mina J.
DOI: 10.1039/c8lc00330k
发表时间: 2018-09-26
期刊: Lab on a chip
影响因子: 6.1
作者:
Hachey SJ;Hughes CCW
通讯作者: Hughes CCW
DOI: 10.1038/s41586-019-1186-3
发表时间: 2019-05-23
期刊: NATURE
影响因子: 64.8
作者:
Ghandi, Mahmoud;Huang, Franklin W.;Sellers, William R.
通讯作者: Sellers, William R.
分子机制和血管生成的临床应用。
DOI: 10.1038/nature10144
发表时间: 2011-05-19
期刊: NATURE
影响因子: 64.8
作者:
Carmeliet, Peter;Jain, Rakesh K.
通讯作者: Jain, Rakesh K.
DOI: 10.1016/j.ccr.2012.08.013
发表时间: 2012-11-13
期刊: Cancer cell
影响因子: 50.3
作者:
Calon A;Espinet E;Palomo-Ponce S;Tauriello DV;Iglesias M;Céspedes MV;Sevillano M;Nadal C;Jung P;Zhang XH;Byrom D;Riera A;Rossell D;Mangues R;Massagué J;Sancho E;Batlle E
通讯作者: Batlle E